DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/2gcjrr/pharmapoint_dry) has announced the addition of the "PharmaPoint: Dry Eye Syndrome - Germany Drug Forecast and Market Analysis to 2022" report to their offering.

“PharmaPoint: Dry Eye Syndrome - Germany Drug Forecast and Market Analysis to 2022”

Dry eye syndrome (DES), or keratoconjunctivitis sicca, is a multifactorial disease of the eye caused by dryness, decreased tear production, or increased tear film evaporation. DES, which is often referred to simply as dry eye, is the most prevalent form of ocular discomfort and irritation. The most common symptoms of DES are ocular irritation and discomfort, foreign body sensation, fatigue, and visual disturbances, which interfere with daily activities. In the elderly population, it is the most common reason for seeking eye care, and this is expected to increase exponentially with an aging demographic.

Germany is the largest DES market in the EU, with a total disease prevalence of over seven million. As in the rest of the EU, there are currently no prescription products approved for the treatment of DES in Germany, and physicians are reliant on artificial tears, sodium hyaluronate, corticosteroids and antibiotics.

Scope

- Overview of the DES including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.

- Detailed information on the key drugs in Germany including product description, safety and efficacy profiles as well as a SWOT analysis.

- Sales forecast for the top drugs in Germany from 2012-2022.

- Analysis of the impact of key events as well the drivers and restraints affecting Germany DES market.

Reasons to Buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return

- Stay ahead of the competition by understanding the changing competitive landscape for DES

- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential

- Make more informed business decisions from insightful and in-depth analysis of drug performance

- Obtain sales forecast for drugs from 2012-2022 in Germany.

Key Topics Covered

1 List of Tables and Figures

2 Introduction

3 Disease Overview

4 Disease Management

5 Competitive Assessment

6 Opportunity and Unmet Need

7 Pipeline Assessment

8 Market Outlook

9 Appendix

For more information visit http://www.researchandmarkets.com/research/2gcjrr/pharmapoint_dry

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.